Suppr超能文献

一个新型正性肌力药物系列。首次通讯:3-、4-、5-、6-、7-和8-吡啶基-2(1H)-喹诺酮衍生物的体外研究

A novel positive inotropic series. 1st communication: in vitro studies of 3-, 4-, 5-, 6-, 7- and 8-pyridyl-2(1H)-quinolone derivatives.

作者信息

Decker N, Grima M, Velly J, Marciniak G, Leclerc G, Schwartz J

机构信息

Institut de Pharmacologie, Faculté de Médecine, Strasbourg, France.

出版信息

Arzneimittelforschung. 1987 Oct;37(10):1108-12.

PMID:2829930
Abstract

A series of 3-, 4-, 5-, 6-, 7- and 8-pyridyl-2(1H)-quinolones and related compounds were evaluated for positive inotropic and vasodilatory activities in vitro. Most of them produced dose-related increases in myocardial contractility on guinea pig isolated atria and perfused heart. In guinea pig atria, the 6-pyridyl molecules were more active than the 5-pyridyl ones; the mean ED50 of compounds 14, 32 and 33 was 4.0 x 10(-7) mol/l i.e. 33 times that of sulmazole; that of compounds 6 and 7 was 2.0 x 10(-5) mol/l. The potencies of the 5- and the 6-pyridyl series also differed by 2 log units on perfused guinea pig heart. The 5- and 6-pyridyl series induced relaxation in precontracted pig coronary artery and coronary vasodilation on perfused guinea pig heart. Compounds 14, 32 and 33 also showed alpha-adrenolytic properties, which were by 0.7 log unit lower than that of phentolamine. These results indicate that this novel cardiotonic series exert positive inotropic and coronary vasodilatory effects.

摘要

对一系列3-、4-、5-、6-、7-和8-吡啶基-2(1H)-喹诺酮类化合物及相关化合物进行了体外正性肌力和血管舒张活性评估。它们中的大多数对豚鼠离体心房和灌注心脏的心肌收缩力产生剂量相关的增加。在豚鼠心房中,6-吡啶基分子比5-吡啶基分子更具活性;化合物14、32和33的平均ED50为4.0×10(-7)mol/L,即舒马唑的33倍;化合物6和7的平均ED50为2.0×10(-5)mol/L。在灌注豚鼠心脏上,5-和6-吡啶基系列的效力也相差2个对数单位。5-和6-吡啶基系列可使预收缩的猪冠状动脉舒张,并使灌注豚鼠心脏的冠状动脉扩张。化合物14、32和33还表现出α-肾上腺素能阻断特性,其活性比酚妥拉明低0.7个对数单位。这些结果表明,这个新型强心剂系列具有正性肌力和冠状动脉舒张作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验